193 related articles for article (PubMed ID: 12813762)
21. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
Widlund KF; Gottvall T
Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
[TBL] [Abstract][Full Text] [Related]
22. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
[TBL] [Abstract][Full Text] [Related]
23. The clinical significance of human alpha-fetoprotein.
Yachnin S
Ann Clin Lab Sci; 1978; 8(2):84-90. PubMed ID: 76458
[TBL] [Abstract][Full Text] [Related]
24. [The significance of alpha-feto-protein (AFP) and human chorionic gonadotrophin (HCG) during the first half of pregnancy (author's transl)].
Dericks-Tan JS; Zehfuss I; Taubert HD
Geburtshilfe Frauenheilkd; 1982 Jan; 42(1):29-34. PubMed ID: 6174393
[TBL] [Abstract][Full Text] [Related]
25. Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in-vitro fertilization.
Lam YH; Yeung WS; Tang MH; Ng EH; So WW; Ho PC
Hum Reprod; 1999 Aug; 14(8):2120-3. PubMed ID: 10438437
[TBL] [Abstract][Full Text] [Related]
26. Amniotic fluid alpha fetoprotein (AFAFP) and maternal serum alpha fetoprotein (MSAFP) in abdominal pregnancies: correlation with extent and site of placental implantation and clinical implications.
Shumway JB; Greenspoon JS; Khouzami AN; Platt LD; Blakemore KJ
J Matern Fetal Med; 1996; 5(3):120-3. PubMed ID: 8796780
[TBL] [Abstract][Full Text] [Related]
27. Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
Spencer K; Crossley JA; Aitken DA; Nicolaides KH
Prenat Diagn; 2005 May; 25(5):358-61. PubMed ID: 15906423
[TBL] [Abstract][Full Text] [Related]
28. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
29. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction.
Bellver J; Lara C; Soares SR; Ramírez A; Pellicer A; Remohí J; Serra V
Hum Reprod; 2005 Sep; 20(9):2623-7. PubMed ID: 15905286
[TBL] [Abstract][Full Text] [Related]
30. A study of oligosaccharide variants of alpha-fetoproteins produced by normal fetuses and fetuses with trisomy 21.
Yamamoto R; Ohkouchi T; Tabata K; Ebina Y; Watari H; Kudo M; Shimizu K; Satomura S; Minakami H; Sakuragi N
Acta Obstet Gynecol Scand; 2005 Dec; 84(12):1145-9. PubMed ID: 16305698
[TBL] [Abstract][Full Text] [Related]
31. First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study.
Lambert-Messerlian G; Dugoff L; Vidaver J; Canick JA; Malone FD; Ball RH; Comstock CH; Nyberg DA; Saade G; Eddleman K; Klugman S; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME
Prenat Diagn; 2006 Aug; 26(8):672-8. PubMed ID: 16764012
[TBL] [Abstract][Full Text] [Related]
32. Nuchal translucency in pregnancies conceived after assisted reproduction technology.
Hui PW; Tang MH; Lam YH; Yeung WS; Ng EH; Ho PC
Ultrasound Obstet Gynecol; 2005 Mar; 25(3):234-8. PubMed ID: 15736183
[TBL] [Abstract][Full Text] [Related]
33. Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ
Prenat Diagn; 2009 Jun; 29(6):570-7. PubMed ID: 19266536
[TBL] [Abstract][Full Text] [Related]
34. [Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization].
Hauzman E; Murber A; Fancsovits P; Papp Z; Urbancsek J
Orv Hetil; 2006 Jul; 147(30):1409-20. PubMed ID: 16977779
[TBL] [Abstract][Full Text] [Related]
35. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection.
Chow SS; Craig ME; Jones CA; Hall B; Catteau J; Lloyd AR; Rawlinson WD
Cytokine; 2008 Oct; 44(1):78-84. PubMed ID: 18703348
[TBL] [Abstract][Full Text] [Related]
36. Sonographic identification of autosomal recessive polycystic kidney disease associated with increased maternal serum/amniotic fluid alpha-fetoprotein.
Townsend RR; Goldstein RB; Filly RA; Callen PW; Anderson RL; Golbus M
Obstet Gynecol; 1988 Jun; 71(6 Pt 2):1008-12. PubMed ID: 2453819
[TBL] [Abstract][Full Text] [Related]
37. Increased risk of placenta previa in pregnancies following IVF/ICSI; a comparison of ART and non-ART pregnancies in the same mother.
Romundstad LB; Romundstad PR; Sunde A; von Düring V; Skjaerven R; Vatten LJ
Hum Reprod; 2006 Sep; 21(9):2353-8. PubMed ID: 16728419
[TBL] [Abstract][Full Text] [Related]
38. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception.
Tul N; Novak-Antolic Z
Prenat Diagn; 2006 Dec; 26(13):1206-11. PubMed ID: 17075793
[TBL] [Abstract][Full Text] [Related]
39. Velamentous umbilical cord insertion may be suspected from maternal serum alpha-fetoprotein and hCG.
Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
Br J Obstet Gynaecol; 1996 Mar; 103(3):209-13. PubMed ID: 8630303
[TBL] [Abstract][Full Text] [Related]
40. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
